- The trend backdrop is active with a 23-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is constructive, supporting the smart-money activity read.
CWK
LSE
Week ended 31 Jul 2026
Weekly Investor Report
Cranswick plc · Consumer Defensive · Packaged Foods
Latest close
5,350 GBP
-2.4%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 0.3% above the Trend Line and sits at 60.8% of its 52-week range. The latest completed week returned -2.4%, after a -3.5% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 58/100.
Setup score
53
out of 100
Latest Close
5,350 GBP
31 Jul 2026
1W Return
-2.4%
latest completed week
4W Return
-3.5%
short-term follow-through
12W Return
1.9%
quarterly tape
Trend Breadth
57.7%
30 of 52 weeks active
Volume Ratio
1.2x
vs 13-week average
- Activity pressure is negative, which weakens the current setup.
- 1 reversal markers appear in the recent smart-money tape.
- Latest weekly return ranks in the weaker part of its sector group.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-2.4%
Latest completed week; four-week move -3.5%.
Indicator stack
77/41
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
58/100
14 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 0.3% above the Trend Line and sits at 60.8% of its 52-week range. The latest completed week returned -2.4%, after a -3.5% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.8412-week average 0.83
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.84Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers
No recent accumulation markers. 1 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -3.5% over four weeks, 1.9% over 12 weeks, and 0.6% over one year. The current trend has remained active for 23 consecutive weeks.
Performance by holding period
Active trend streak23 weeks
Active weeks in one year30
Trend breadth57.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.02Latest activity-pressure read.
Pressure change-105.3%Four-week change in activity pressure.
Leadership-5.76Latest relative-leadership reading.
RS change-236.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers.
Factor week 26 Jul 2026
Financial statements through 31 Mar 2026
Field coverage 91%
Model confidence 87%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength23/100Blend of value, momentum, and quality. Underlying universe rank 78; rank 1 is best.
Value14/100Relative valuation strength. Underlying universe rank 87; rank 1 is best.
Quality17/100Profitability and accounting quality. Underlying universe rank 84; rank 1 is best.
Momentum82/100Medium-term price momentum. Underlying universe rank 19; rank 1 is best.
Growth88/100Revenue and earnings growth. Underlying universe rank 13; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework43/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 18.5x Price divided by trailing earnings.
- Price / sales
- 1.0x Market value relative to trailing revenue.
- EV / EBITDA
- 9.5x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 3.4% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 15.8% Gross profit retained from each unit of revenue.
- Operating margin
- 7.8% Operating profit retained from revenue.
- Free-cash-flow margin
- 3.7% Free cash flow generated from revenue.
- Return on invested capital
- 13.1% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 9.5% Latest one-year revenue growth.
- EPS growth
- 17.6% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 38.4% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 2.1% Cash dividends relative to market value.
- Buyback yield
- 0.5% Net share repurchases relative to market value.
- Shareholder yield
- 2.6% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.7x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment58/100
Weighted news tone is neutral across 14 relevant articles.
3 positive · 11 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-6.5%Distance below the 52-week high.
13-week volatility2.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher12 of 2613 weeks finished lower.
Best week+6.0%Week of 22 May.
Worst week-3.9%Week of 19 Jun.
Latest week-2.4%Week of 31 Jul.
Shape of recent returns
Strong gains2
Modest gains10
Flat weeks1
Modest losses13
Sharp losses0
Recent vol2.7%13-week weekly-return volatility.
Base vol2.3%52-week weekly-return volatility.
Up/down split24/27Count of positive and negative weeks in the 52-week window.
Average skew2.0% / -1.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorGB Consumer Defensive
4-week rank47 / 58
Group average1.1%
Trend breadth44.8%
Trend44.8%active weekly trend signals
MD60.3%positive activity pressure
RS31.0%positive relative leadership
Four-week leaders
IndustryGB Packaged Foods
4-week rank12 / 17
Group average-1.1%
Trend breadth64.7%
Trend64.7%active weekly trend signals
MD52.9%positive activity pressure
RS29.4%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape54/100
Trend, activity pressure, participation, and risk combine to a 54/100 tape read.
Indicator analysis68/100Latest 12-week confirmation: trend 12/12, activity pressure 11/12, relative leadership 1/12.
Activity pressure 0.84; 1 reversal markers Factors31/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 37; Small Cap Core rank 73 SVQF43/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 145.5 of 254 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment58/100Weighted news tone is neutral across 14 relevant articles.
Cranswick shareholders back AGM resolutions amid governance scrutiny Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 5,350 GBP | -2.4% | 5,336 GBP | 4,723 GBP | -0.02 | -5.76 | 694.6K | On |
| 24 Jul 2026 | 5,480 GBP | -0.7% | 5,322 GBP | 4,710 GBP | 0.39 | -2.61 | 421.6K | On |
| 17 Jul 2026 | 5,520 GBP | 1.4% | 5,310 GBP | 4,697 GBP | 0.60 | -0.90 | 409.0K | On |
| 10 Jul 2026 | 5,445 GBP | -1.8% | 5,289 GBP | 4,683 GBP | 0.45 | -1.51 | 864.6K | On |
| 3 Jul 2026 | 5,543 GBP | -1.1% | 5,277 GBP | 4,668 GBP | 0.44 | -1.71 | 534.9K | On |
| 26 Jun 2026 | 5,602 GBP | 5.0% | 5,264 GBP | 4,654 GBP | 0.20 | 0.61 | 93.6K | On |
| 19 Jun 2026 | 5,337 GBP | -3.9% | 5,242 GBP | 4,638 GBP | 0.12 | -3.07 | 120.1K | On |
| 12 Jun 2026 | 5,553 GBP | 1.1% | 5,226 GBP | 4,625 GBP | 0.39 | -0.45 | 123.2K | On |
| 5 Jun 2026 | 5,490 GBP | 0.0% | 5,204 GBP | 4,611 GBP | 0.23 | -0.86 | 122.6K | On |
| 29 May 2026 | 5,490 GBP | -0.5% | 5,186 GBP | 4,597 GBP | 0.22 | -1.52 | 922.3K | On |
| 22 May 2026 | 5,520 GBP | 6.0% | 5,174 GBP | 4,582 GBP | 0.24 | -1.83 | 1.2M | On |
| 15 May 2026 | 5,210 GBP | -0.8% | 5,157 GBP | 4,567 GBP | 0.25 | -5.14 | 933.6K | On |
| 8 May 2026 | 5,250 GBP | -2.2% | 5,147 GBP | 4,553 GBP | 0.46 | -5.15 | 815.4K | On |
| 1 May 2026 | 5,370 GBP | -0.4% | 5,135 GBP | 4,541 GBP | 0.68 | -4.54 | 817.6K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.